Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender (Q56944785)

From Wikidata
Jump to navigation Jump to search
article
edit
Language Label Description Also known as
English
Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender
article

    Statements

    Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit